Alterations of the glutamatergic system in diabetes mellitus
- PMID: 37747631
- DOI: 10.1007/s11011-023-01299-z
Alterations of the glutamatergic system in diabetes mellitus
Abstract
Diabetes mellitus (DM) is a chronic disease characterized by elevated blood glucose levels caused by a lack of insulin production (type 1 diabetes) or insulin resistance (type 2 diabetes). It is well known that DM is associated with cognitive deficits and metabolic and neurophysiological changes in the brain. Glutamate is the main excitatory neurotransmitter in the central nervous system that plays a key role in synaptic plasticity, learning, and memory processes. An increasing number of studies have suggested that abnormal activity of the glutamatergic system is implicated in the pathophysiology of DM. Dysfunction of glutamatergic neurotransmission in the central nervous system can provide an important neurobiological substrate for many disorders. Magnetic resonance spectroscopy (MRS) is a non-invasive technique that allows a better understanding of the central nervous system factors by measuring in vivo the concentrations of brain metabolites within the area of interest. Here, we briefly review the MRS studies that have examined glutamate levels in the brain of patients with DM. The present article also summarizes the available data on abnormalities in glutamatergic neurotransmission observed in different animal models of DM. In addition, the role of gut microbiota in the development of glutamatergic alterations in DM is addressed. We speculate that therapeutic strategies targeting the glutamatergic system may be beneficial in the treatment of central nervous system-related changes in diabetic patients.
Keywords: Diabetes mellitus; Glutamate; Gut microbiota; Magnetic resonance spectroscopy; Neurochemical alteration; Neurotransmission.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The neurometabolic profiles of GABA and Glutamate as revealed by proton magnetic resonance spectroscopy in type 1 and type 2 diabetes.PLoS One. 2020 Oct 29;15(10):e0240907. doi: 10.1371/journal.pone.0240907. eCollection 2020. PLoS One. 2020. PMID: 33120406 Free PMC article.
-
Dynamic alterations in the central glutamatergic status following food and glucose intake: in vivo multimodal assessments in humans and animal models.J Cereb Blood Flow Metab. 2021 Nov;41(11):2928-2943. doi: 10.1177/0271678X211004150. Epub 2021 May 26. J Cereb Blood Flow Metab. 2021. PMID: 34039039 Free PMC article. Clinical Trial.
-
Altered brain metabolites in patients with diabetes mellitus and related complications - evidence from 1H MRS study.Biosci Rep. 2018 Sep 7;38(5):BSR20180660. doi: 10.1042/BSR20180660. Print 2018 Oct 31. Biosci Rep. 2018. PMID: 30104398 Free PMC article. Review.
-
Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.Neurochem Res. 2019 Jan;44(1):102-116. doi: 10.1007/s11064-018-2521-z. Epub 2018 Apr 3. Neurochem Res. 2019. PMID: 29616444 Free PMC article. Review.
-
Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus.Arch Gen Psychiatry. 2009 Aug;66(8):878-87. doi: 10.1001/archgenpsychiatry.2009.86. Arch Gen Psychiatry. 2009. PMID: 19652127
References
-
- Ajilore O, Haroon E, Kumaran S et al (2007) Measurement of brain metabolites in patients with type 2 diabetes and Major Depression using Proton magnetic resonance spectroscopy. Neuropsychopharmacol 32:1224–1231. https://doi.org/10.1038/sj.npp.1301248 - DOI
-
- Andersen JV, Nissen JD, Christensen SK et al (2017a) Impaired hippocampal glutamate and glutamine metabolism in the db/db mouse model of type 2 diabetes Mellitus. Neural Plast 2017:2107084. https://doi.org/10.1155/2017/2107084 - DOI - PubMed - PMC
-
- Andersen JV, Christensen SK, Nissen JD, Waagepetersen HS (2017b) Improved cerebral energetics and ketone body metabolism in db/db mice. J Cereb Blood Flow Metab 37:1137–1147. https://doi.org/10.1177/0271678X16684154 - DOI - PubMed
-
- Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of Comorbid Depression in adults with DiabetesA meta-analysis. Diabetes Care 24:1069–1078. https://doi.org/10.2337/DIACARE.24.6.1069 - DOI - PubMed
-
- Anu J, Peeyush Kumar T, Nandhu MS, Paulose CS (2010) Enhanced NMDAR1, NMDA2B and mGlu5 receptors gene expression in the cerebellum of insulin induced hypoglycaemic and streptozotocin induced diabetic rats. Eur J Pharmacol 630:61–68. https://doi.org/10.1016/J.EJPHAR.2009.12.024 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical